startup series
for contracting VAP. VAPCare is an
intelligent, automated, closed-loop,
secretion management system for ICU
patients on long term ventilation. It is a
first in the world device, sensor-based,
secretion management system which
can functionally replace an ICU nurse.
KEY MILESTONES OF
INNACCEL
• The company has commercially
launched a product in Q4 of the
year 2016
• Filed for one patent and
exclusively licensed another
• Received BIG and SBIRI grants
from DBT in 2014 and 2016
• Received Lemelson foundation
grant 2017
• Grown from 2 people to a team
of 12 full time employees
• Conducted innovation
workshops with reputed
educational institutes like
JIPMER, AIIMS, St. Johns
Medical College, NID and IIT
Delhi.
• Invested in and are currently
innovating 2 promising start ups
Sattva Medtech and Coeo Labs
which will be launching products
this year
30
BioVoiceNews | June 2017
The product is being developed with our
partner company Coeo Labs and will be
launched in the market in early 2017.
Way forward
The research and development team at
InnAccel is also working on a Eustachian
tube diagnostic and intervention
device. It also plans to develop platform
of minimally invasive products and
are exploring solutions for problems
like tracheal stenosis, salivary duct
obstruction and lacrimal duct blockage.
It is obvious that the company has set
very high goals that are equally backed
with experience, funds and talent.
Aiming to foster the development of least
50 novel medical devices and diagnostics
by 2020, InnAccel is optimistic about
launching 25 critical medtech products
in India by 2025. Given the presence of
a highly passionate team that they have
currently, their task though difficult but
doesn’t seem impossible.